This is a single-center, open-label, randomized, two way crossover study to investigate the food effect on the pharmacokinetics of ACT-541468 in healthy male subjects.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
20
ACT-541468 50 mg film-coated tablets
CEPHA s.r.o.
Pilsen, Czechia
Pharmacokinetic endpoint: AUC0-24
Area under the plasma concentration-time curve (AUC) from time zero to 24 h
Time frame: Multiple timepoints; duration: up to 48 hours in each treatment period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.